ConductScience.org, home

Paper26322834

Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.

Ribeiro L and 22 others. Invest Ophthalmol Vis Sci, 2015. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2. Papers, record 26322834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26322834

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.
PubMed
Journal
Invest Ophthalmol Vis Sci
PubMed
Year
2015
PubMed
Publication types
Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2026-05-18
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ribeiro LLuisa
2Bandello FFrancesco
3Tejerina ANAmparo Navea
4Vujosevic SStela
5Varano MMonica
6Egan CCatherine
7Sivaprasad SSobha
8Menon GGeeta
9Massin PPascale
10Verbraak FDFrank D
11Lund-Andersen HHenrik
12Martinez JPJose P
13Jürgens IIgnasi
14Smets EErica
15Coriat CCaroline
16Wiedemann PPeter
17Ágoas VVictor
18Querques GGiuseppe
19Holz FGFrank G
20Nunes SSandrina

Source PubMed

See all 23 authorsDownload CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Diabetic RetinopathyMajor topic
RetinaMajor topic
Tomography, Optical CoherenceMajor topic
Visual AcuityMajor topic
Female
Humans
Male
Middle Aged
Disease Progression
Follow-Up Studies
Prognosis
Prospective Studies
Time Factors

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01145599Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive ProceduresDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
39061684Distribution of Microaneurysms and Hemorrhages in Accordance with the Grading of Diabetic Retinopathy in Type Diabetes Patients.Diagnostics (Basel)2024https://conductscience.org/library/papers/39061684PubMed
36495395Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study.Ophthalmol Ther2023https://conductscience.org/library/papers/36495395PubMed
35241519In Vivo Imaging of Ischemia/Reperfusion-mediated Aminopeptidase N Expression in Surgical Rat Model Using 68Ga-NOTA-c(NGR).In Vivo2022https://conductscience.org/library/papers/35241519PubMed
34865186Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy.Ophthalmol Ther2022https://conductscience.org/library/papers/34865186PubMed
32408522Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.J Clin Med2020https://conductscience.org/library/papers/32408522PubMed
30120928Correlation of spectral domain optical coherence tomography with histology and electron microscopy in the porcine retina.Exp Eye Res2018https://conductscience.org/library/papers/30120928PubMed
29896271MicroRNA-27a protects retinal pigment epithelial cells under high glucose conditions by targeting TLR4.Exp Ther Med2018https://conductscience.org/library/papers/29896271PubMed
28539797Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects.Eye Brain2016https://conductscience.org/library/papers/28539797PubMed
27847629Human retinal microvascular imaging using adaptive optics scanning light ophthalmoscopy.Int J Retina Vitreous2016https://conductscience.org/library/papers/27847629PubMed
27344955Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.Exp Eye Res2016https://conductscience.org/library/papers/27344955PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26322834

GET https://conductscience.org/api/papers/v1/26322834/authors?page=2